Zagotenemab

未知生产厂商

Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。